Abstract: A method of inducing cell death in a subject includes administering to the subject a plurality of cell targeted nanobubbles that are internalized by the target cell and insonating nanobubbles internalized into the target cell with ultrasound energy effective to promote inertial cavitation of the internalized nanobubbles and apoptosis and/or necrosis of the target cell.

Abstract: Cancer imaging methods and cancer treatment methods using thermotherapy and drug delivery are disclosed herein. In one embodiment, the temperature of heated tissue is determined from radio-frequency data from an ultrasound transducer based upon a change in backscattered energy of acoustic harmonics. In another embodiment, a plurality of nanocarriers containing an anti-tumor medication are administered to a patient, and are excited in a first non-thermal ultrasound mode and/or a second thermal ultrasound mode using an ultrasound source. In yet another embodiment, a plurality of nanoparticles are administered to a patient, then at least some of the nanoparticles are heated along with tissue at a site of a tumor, and a photoacoustic imaging unit is used to determine a temperature of the heated tissue at the site of the tumor.

Abstract: Methods and apparatuses for controlling the size of microbubbles are provided herein. The methods include forming a microbubble in a liquid at an inlet end of a liquid microchannel, the liquid microchannel having an outlet end spaced from the inlet end and a liquid microchannel conduit extending therebetween. As the liquid is propelled along a length of the liquid microchannel, the liquid carry the microbubble, a negative pressure is applied to a first very low pressure microchannel having a first end, a second end spaced from the first end and a first very low pressure microchannel conduit extending between the first end and the second end and having a portion thereof being laterally spaced from and adjacent to a portion of the liquid microchannel conduit. The negative pressure withdraws air from the microbubble in the liquid microchannel to shrink the microbubble as the microbubble travels along the portion of the liquid microchannel conduit.

Abstract: The present disclosure provides a method of detecting a presence of methemoglobin in a tissue-of-interest using photoacoustic techniques, the method including acquiring photoacoustic data sets at different wavelengths from the tissue-of-interest, computing a relationship between at least two of the data sets, and analyzing the relationship to determine the presence of methemoglobin in the tissue-of-interest. Methods of monitoring therapy are also disclosed.

Abstract: Provided herein is a method to detect, characterize and classify a particle. A light source and an ultrasound transducer are controlled to irradiate the particle with light and an ultrasound pulse. A feature associated with the particle is determined by processing ultrasound data resulting from the particle being irradiated. The feature is compared to a reference to determine at least one property of the particle. According to some non-limiting implementations, the feature comprises a power spectrum of the particle. According to some non-limiting implementations, the ultrasound data is processed to determine characteristics in a range of about 100 MHz to about 1000 MHz of the power spectrum. According to some non-limiting implementations, the ultrasound pulse is in a range of about 100 MHz to about 1000 MHz. A computing device to detect, characterize and classify a particle is also provided.

Abstract: Provided herein is a method to detect, characterize and classify a particle comprising: controlling a light source and an ultrasound transducer to irradiate the particle with light and an ultrasound pulse; determining a feature associated with the particle by processing ultrasound data resulting from the particle being irradiated; and comparing the feature to a reference to determine at least one property of the particle. According to some non-limiting implementations, the feature comprises a power spectrum of the particle. According to some non-limiting implementations, the ultrasound data is processed to determine characteristics in a range of about 100 MHz to about 1000 MHz of the power spectrum. According to some non-limiting implementations, the ultrasound pulse is in a range of about 100 MHz to about 1000 MHz. A computing device to detect, characterize and classify a particle is also provided.

Abstract: Provided herein are methods and systems to determine at least one mechanical property of a tissue sample and, based upon the determined at least one mechanical property, whether the tissue sample comprises atherosclerotic plaque. The method comprises generating a shear wave in an arterial tissue sample by applying an acoustic impulse thereto; measuring propagation of the shear wave via an optical coherence elastography apparatus; determining at least one mechanical property of the arterial tissue sample based on the propagation of the shear wave; and comparing the at least one mechanical property of the arterial tissue sample to a reference data set to determine whether the arterial tissue sample comprises atherosclerotic plaque. A hybrid optical coherence tomography imaging/acoustic radiation force impulse system is disclosed.

Abstract: A computing device system and method for detecting cell death in a biological sample is provided. A plurality of optical coherence tomography (OCT) data sets are received, each representative of OCT backscatter data collected from the biological sample and comprising respective signal fluctuation as a function of time at different respective times over a given time period. Respective indications of respective signal decorrelation rates are determined for each of the plurality of OCT data sets at each of the different respective time.

Abstract: A method of detecting cellular damage within a subject comprises transmitting low frequency ultrasound (20 MHz or below) into a selected site within the subject wherein the selected site has been exposed to a stress capable of causing cellular death at the selected site. At least a portion of ultrasound backscattered from the ultrasound transmitted into the selected site is received. The received backscattered ultrasound is compared to a control backscatter measurement. An increase or a decrease in intensity or spectral slope of the received backscattered ultrasound when compared to the control backscatter measurement indicates cellular death or damage at the selected site within the subject.

Abstract: Optical Coherence Tomography (OCT) is a high-resolution, non-invasive technique to image subsurface tissue and tissue functions. A broadband light source illuminates an object and the reflected photons are processed using an interferometer, demodulated into inphase and quadrature components and then digitized. The captured data contains information about the velocity of the moving scatterers but current Doppler estimation algorithms have a limited velocity detection range. Using a two dimensional velocity estimation, Doppler OCT (DOCT) can be used for the detection of in vivo aortic blood flow rates of over 1 m/s peak velocity through an esophageal DOCT probe. Previous methods have used a transverse Kasai (TK) autocorrelation estimation to estimate the velocity which is good for slow velocities, such as in the microvasculature. By calculating the Kasai autocorrelation with a lag in the depth or axial direction, backscattered frequency information is obtained which yields high velocity rate information.

Abstract: Optical Coherence Tomography (OCT) is a high-resolution, non-invasive technique to image subsurface tissue and tissue functions. A broadband light source illuminates an object and the reflected photons are processed using an interferometer, demodulated into inphase and quadrature components and then digitized. The captured data contains information about the velocity of the moving scatterers but current Doppler estimation algorithms have a limited velocity detection range. Using a two dimensional velocity estimation, Doppler OCT (DOCT) can be used for the detection of in vivo aortic blood flow rates of over 1 m/s peak velocity through an esophageal DOCT probe. Previous methods have used a transverse Kasai (TK) autocorrelation estimation to estimate the velocity which is good for slow velocities, such as in the microvasculature. By calculating the Kasai autocorrelation with a lag in the depth or axial direction, backscattered frequency information is obtained which yields high velocity rate information.

Abstract: A method of detecting cellular damage within a subject comprises transmitting low frequency ultrasound (20 MHz or below) into a selected site within the subject wherein the selected site has been exposed to a stress capable of causing cellular death at the selected site. At least a portion of ultrasound backscattered from the ultrasound transmitted into the selected site is received. The received backscattered ultrasound is compared to a control backscatter measurement. An increase or a decrease in intensity or spectral slope of the received backscattered ultrasound when compared to the control backscatter measurement indicates cellular death or damage at the selected site within the subject.

Abstract: A non-invasive method of monitoring apoptosis in cell culture, ex-vivo tissues and in-vivo tissues using high frequency ultrasound imaging is provided.